DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
Trusted Resources: Community Center
Online groups, photo galleries and blogs
Hope and Destiny Jr. Learning Guide and Workbook
Sickle cell disease (SCD) is a group of blood disorders that affect hemoglobin, the molecule in red blood cells that carries oxygen to cells throughout the body. The CDC estimates that 90,000 to 100,000 Americans have SCD, making it a major public health concern that brings with it considerable financial consequences due to the higher number of hospitalizations and increased medical expenditures that sickle cell patients experience over a lifetime compared to the general public.
Our best-selling book series today is the Hope & Destiny series, which includes a book written just for adolescents and families impacted by sickle cell disease.
Hope and Destiny Jr. is now available in this new 48-page abridged workbook edition for young SCD patients to learn more about their disease, identify their pain, track symptoms and side-effects of treatments and medications, and write about the unique challenges and changes they may be experiencing so they can discuss with their doctor.
+myBinderRelated Content
-
news & eventsBoston Children’s Hospital receives grant for sickle cell disease researchThe Bill and Melinda Gates Foundation aw...
-
education & researchComparison of the Safety Profile of Sickle Cell Disease Patients Treated with Hydroxycarbamide in Off-Label Versus i...ESCORT-HU (European Sickle Cell Disease ...
-
people & placesKenneth Ataga, MDDr. Ataga's clinical interest is in clas...
-
people & placesBryan B. Bushman, PhDBryan Bushman, Ph.D., is a licensed clin...
-
education & researchSickle Cell Disease: Tipping the Balance of Genomic Research to Catalyse Discoveries in AfricaThe completion of the Human Genome Proje...
-
news & eventsProdigy’s death shines light on slow progress against sickle cell diseaseThe death of the rap artist Prodigy (Alb...
-
news & eventsSiklos®, the first and only hydroxyurea-based treatment for pediatric patients with sickle cell anemia, now availab...Medunik USA, a company dedicated to impr...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.